| PERIOD ENDING | 3-Oct-09 | 4-Jul-09 | 4-Apr-09 | 31-Dec-08 | | Total Revenue | 35,713 | 34,515 | 31,449 | 56,315 | | Cost of Revenue | 16,111 | 15,152 | 15,189 | 24,043 | | | Gross Profit | 19,602 | 19,363 | 16,260 | 32,272 | | | Operating Expenses | | Research Development | 2,802 | 3,285 | 3,479 | 3,503 | | Selling General and Administrative | 17,640 | 18,262 | 19,123 | 22,999 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 1,410 | 1,389 | 1,291 | 1,212 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (2,250) | (3,573) | (7,633) | 4,558 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 214 | 873 | (503) | (915) | | Earnings Before Interest And Taxes | (2,036) | (2,700) | (8,136) | 3,643 | | Interest Expense | 3 | 3 | 3 | 2 | | Income Before Tax | (2,039) | (2,703) | (8,139) | 3,641 | | Income Tax Expense | (766) | (599) | (1,554) | 1,443 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (1,273) | (2,104) | (6,585) | 2,198 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (1,273) | (2,104) | (6,585) | 2,198 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($1,273) | ($2,104) | ($6,585) | $2,198 |
|
0.08% Nasdaq 
0.29%
Income Statement
